During a House Ways and Means Committee hearing before the congressional recess, Rep. Michelle Fischbach (R-MN) questioned Vice President of Clinical Quality and Population Health Officer at Avera Health, David A. Basel, M.D. about the effect of prior authorization policies on rural communities.
